We are live on
!
Find out more
VVA
Vida Ventures Advisors Portfolio holdings
AUM
$29.4M
1-Year Est. Return
93.58%
This Fund
S&P 500
This Quarter
Est. Return
+88.93%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$29.4M
AUM Growth
+$13.5M
(+85%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kyverna Therapeutics
KYTX
$481M
| $27.1M | 92.41% |
4,523,924
| – | – |
|
2
Allogene Therapeutics
ALLO
$604M
| $2.23M | 7.59% |
1,798,163
| – | – |
|
Similar funds
NC
PIM
NCPI
TCM
RE
VM
BCA
VCM
Vida Ventures Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Vida Ventures Advisors held 2 positions worth $29.4M, up 85% from $15.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Vida Ventures Advisors's ten largest holdings make up 100% of its $29.4M portfolio in Q3 2025.
- Vida Ventures Advisors opened 0 new positions and closed 0 in Q3 2025.
- Vida Ventures Advisors's portfolio value rose 85% quarter-over-quarter to $29.4M.
Based on Vida Ventures Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.